These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19860646)

  • 21. The potential for multidrug-resistant influenza.
    van der Vries E; Schutten M; Boucher CA
    Curr Opin Infect Dis; 2011 Dec; 24(6):599-604. PubMed ID: 22001947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antivirals and influenza: frequency of resistance.
    Monto AS
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral resistance during pandemic influenza: implications for stockpiling and drug use.
    Arino J; Bowman CS; Moghadas SM
    BMC Infect Dis; 2009 Jan; 9():8. PubMed ID: 19161634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance.
    Hu Y; Lu S; Song Z; Wang W; Hao P; Li J; Zhang X; Yen HL; Shi B; Li T; Guan W; Xu L; Liu Y; Wang S; Zhang X; Tian D; Zhu Z; He J; Huang K; Chen H; Zheng L; Li X; Ping J; Kang B; Xi X; Zha L; Li Y; Zhang Z; Peiris M; Yuan Z
    Lancet; 2013 Jun; 381(9885):2273-9. PubMed ID: 23726392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antivirals for pandemic influenza.
    Hayden FG
    J Infect Dis; 1997 Aug; 176 Suppl 1():S56-61. PubMed ID: 9240696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Issues in pharmacotherapy of 2009 H1N1 influenza infection.
    Gupta YK; Padhy BM
    J Postgrad Med; 2010; 56(4):321-7. PubMed ID: 20935410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparing for pandemic influenza: should hospitals stockpile oseltamivir?
    Cinti S; Chenoweth C; Monto AS
    Infect Control Hosp Epidemiol; 2005 Nov; 26(11):852-4. PubMed ID: 16320980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral management of seasonal and pandemic influenza.
    Hayden FG; Pavia AT
    J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide inhibitors against influenza virus.
    Rajik M; Yusoff K
    Antivir Chem Chemother; 2011 Mar; 21(4):151-4. PubMed ID: 21602612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiviral resistance in influenza viruses--implications for management and pandemic response.
    Hayden FG
    N Engl J Med; 2006 Feb; 354(8):785-8. PubMed ID: 16495389
    [No Abstract]   [Full Text] [Related]  

  • 31. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.
    Bright RA; Shay DK; Shu B; Cox NJ; Klimov AI
    JAMA; 2006 Feb; 295(8):891-4. PubMed ID: 16456087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza virus resistance to neuraminidase inhibitors.
    Samson M; Pizzorno A; Abed Y; Boivin G
    Antiviral Res; 2013 May; 98(2):174-85. PubMed ID: 23523943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral therapy in seasonal influenza and 2009 H1N1 pandemic influenza: Korean experiences and perspectives.
    Song JY; Noh JY; Choi WS; Cheong HJ; Kim WJ
    Expert Rev Anti Infect Ther; 2015; 13(11):1361-72. PubMed ID: 26256778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza a (H1N1) outbreak and challenges for pharmacotherapy.
    Chawla R; Sharma RK; Bhardwaj JR
    Indian J Physiol Pharmacol; 2009; 53(2):113-26. PubMed ID: 20112815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug-resistant influenza viruses: an overview].
    Hatakeyama S
    Nihon Rinsho; 2010 Sep; 68(9):1671-8. PubMed ID: 20845746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healthcare system cost evaluation of antiviral stockpiling for pandemic influenza preparedness.
    Li Y; Hsu EB; Links JM
    Biosecur Bioterror; 2010 Jun; 8(2):119-28. PubMed ID: 20569054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HHS finalizes antiviral guidance for pandemic flu preparedness.
    Traynor K
    Am J Health Syst Pharm; 2009 Feb; 66(3):206-7. PubMed ID: 19179629
    [No Abstract]   [Full Text] [Related]  

  • 38. The pandemic threat: are we prepared?
    Lewis KK
    Issue Brief (Mass Health Policy Forum); 2006 Jun; (29):1-14. PubMed ID: 16886304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy.
    Pizzorno A; Padey B; Terrier O; Rosa-Calatrava M
    Front Immunol; 2019; 10():531. PubMed ID: 30941148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspectives on antiviral use during pandemic influenza.
    Hayden FG
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1877-84. PubMed ID: 11779387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.